For Peer Review
20
28. Resende FA, Barcala CAMA, Faria MCS, Kato FH, Cunha WR, Tavares DC:
Antimutagenicity of ursolic acid and oleanolic acid against doxorubicin-induced
clastogenesis in balb/c mice. Life Sciences 2006; 79:1268-1273.
29. Young HS, Chung HY, Lee CK, Park KI, Yokozawa T, Oura H: Ursolic acid inhibits
aflatoxin B
1
-induced mutagenicity in a Salmonella assay system. Biological and
Pharmaceutical Bulletin 1994; 17(7):990-2
30. Saleem M, Afaq F, Adhami VM, Mukhtar H: Lupeol modulates NF-^B and PI3K/Akt
pathways and inhibits skin cancer in CD-1 mice. Oncogene 2004; 23:5203-5214.
31. Preetha SP, Kanniappan M, Selvakumar E, Nagaraj M, Varalakshmi P: Lupeol
ameliorates aflatoxin B-1-induced peroxidative hepatic damage in rats. Comparative
Biochemistry and Physiology C-Toxicology & Pharmacology 2006; 143 (3):333-339.
32. Cardoso CR, Colus IMS, Bernardi CC, Sannomiya M, Vilegas W, Varanda EA:
Mutagenic activity promoted by amentoflavone and methanol extract of Byrsonima crassa
Niedenzu. Toxicology 2006; 225(1):55-63.
33. Sannomiya M,
Cardoso CRP, Figueiredo MF, Rodrigues CM, Santos LC, Santos FV,
Serpeloni JM, Cólus IMS, Vilegas W, Varanda EA: Mutagenic evaluation and chemical
investigation of Byrsonima intermedia A. Juss. leaf extracts. Journal of
Ethnopharmacology 2007; 112: 319-326.
34. Rietjens IMCM, Boersma MG, van der Woude H, Jeurissen SMF, Schutte ME, Alink
GM: Flavonoids and alkenylbenzenes: Mechanisms of mutagenic action and carcinogenic
risk. Mutation Research 2005; 574:124-138.
35. Heim KE, Tagliaferro AR, Bobilya DJ: Flavonoid antioxidants: Chemistry, metabolism
and structure-activity relationships. Journal of Nutritional Biochemistry 2002;13:572–584.
Page 20 of 60
Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801
Journal of Medicinal Food
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60